| Norman C Rokosz, MD | |
|
200 Ne Mother Joseph Pl, Suite 110, Vancouver, WA 98664-3299 | |
| (360) 254-6161 | |
| (360) 449-1146 |
| Full Name | Norman C Rokosz |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 31 Years |
| Location | 200 Ne Mother Joseph Pl, Vancouver, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003863697 | NPI | - | NPPES |
| 8256257 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD38687 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alaska Native Medical Center | Anchorage, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alaska Native Tribal Health Consortium | 6709780265 | 457 |
News Archive
In a new paper published on the preprint journal bioRxiv in April 2020, researcher T. Konishi argues that the coronavirus family is a constellation of pandemic pathogens, that includes the currently spreading severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
A latest study reveals that the risk for stroke maybe tied to blood type, with men and women with type AB and women with type B facing greater risk than people with type O. Researchers add that this study does not prove the link but it agrees with other studies that have tied A, B, and AB to heart attack and to blood clots in the legs. And type O has been linked to a heightened risk for bleeding, which implies less chance of the clots that are responsible for most strokes.
Hip fracture is associated with an increase in short-term mortality (death within one year) for women ages 65 to 79 years and healthy women ages 80 years and older, although the risk returns to previous levels after one year for women ages 70 years and older, according to a report published Online First by Archives of Internal Medicine, one of the JAMA/Archives journals.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational New Drug (IND) application for its doxorubicin targeted conjugate compound, AEZS-108, in luteinizing hormone releasing hormone (LHRH) receptor positive urothelial (bladder) cancer.
Cancer Research UK this week launches a new trial for patients with bowel cancer that has spread to the liver to see whether a new radiotherapy treatment technique is more effective than standard chemotherapy.
› Verified 5 days ago
| Entity Name | Alaska Native Tribal Health Consortium |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437189339 PECOS PAC ID: 6709780265 Enrollment ID: O20031125000772 |
News Archive
In a new paper published on the preprint journal bioRxiv in April 2020, researcher T. Konishi argues that the coronavirus family is a constellation of pandemic pathogens, that includes the currently spreading severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
A latest study reveals that the risk for stroke maybe tied to blood type, with men and women with type AB and women with type B facing greater risk than people with type O. Researchers add that this study does not prove the link but it agrees with other studies that have tied A, B, and AB to heart attack and to blood clots in the legs. And type O has been linked to a heightened risk for bleeding, which implies less chance of the clots that are responsible for most strokes.
Hip fracture is associated with an increase in short-term mortality (death within one year) for women ages 65 to 79 years and healthy women ages 80 years and older, although the risk returns to previous levels after one year for women ages 70 years and older, according to a report published Online First by Archives of Internal Medicine, one of the JAMA/Archives journals.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational New Drug (IND) application for its doxorubicin targeted conjugate compound, AEZS-108, in luteinizing hormone releasing hormone (LHRH) receptor positive urothelial (bladder) cancer.
Cancer Research UK this week launches a new trial for patients with bowel cancer that has spread to the liver to see whether a new radiotherapy treatment technique is more effective than standard chemotherapy.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Norman C Rokosz, MD 200 Ne Mother Joseph Pl, Suite 210, Vancouver, WA 98664-3299 Ph: (360) 254-6161 | Norman C Rokosz, MD 200 Ne Mother Joseph Pl, Suite 110, Vancouver, WA 98664-3299 Ph: (360) 254-6161 |
News Archive
In a new paper published on the preprint journal bioRxiv in April 2020, researcher T. Konishi argues that the coronavirus family is a constellation of pandemic pathogens, that includes the currently spreading severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
A latest study reveals that the risk for stroke maybe tied to blood type, with men and women with type AB and women with type B facing greater risk than people with type O. Researchers add that this study does not prove the link but it agrees with other studies that have tied A, B, and AB to heart attack and to blood clots in the legs. And type O has been linked to a heightened risk for bleeding, which implies less chance of the clots that are responsible for most strokes.
Hip fracture is associated with an increase in short-term mortality (death within one year) for women ages 65 to 79 years and healthy women ages 80 years and older, although the risk returns to previous levels after one year for women ages 70 years and older, according to a report published Online First by Archives of Internal Medicine, one of the JAMA/Archives journals.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational New Drug (IND) application for its doxorubicin targeted conjugate compound, AEZS-108, in luteinizing hormone releasing hormone (LHRH) receptor positive urothelial (bladder) cancer.
Cancer Research UK this week launches a new trial for patients with bowel cancer that has spread to the liver to see whether a new radiotherapy treatment technique is more effective than standard chemotherapy.
› Verified 5 days ago
Hoang N. Le, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 Ne Mother Joseph Pl, Suite 110, Vancouver, WA 98664 Phone: 360-256-8584 Fax: 360-449-1146 | |
Jay D. Miller, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 200 Ne Mother Joseph Pl, Suite 110, Vancouver, WA 98664 Phone: 360-256-8584 Fax: 360-449-1146 | |
Ashok Modha, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 Ne Mother Joseph Pl, Suite 110, Vancouver, WA 98664 Phone: 360-254-6161 Fax: 360-449-1146 | |
George B. Shanno, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 Ne Mother Joseph Pl, Suite 110, Vancouver, WA 98664 Phone: 360-254-6161 Fax: 360-449-1146 | |
Andrew Nicholas Nemecek, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 Ne Mother Joseph Pl Ste 300, Vancouver, WA 98664 Phone: 360-254-6161 Fax: 360-449-1146 | |
Dr. Wael Yacoub Musleh, MD., PH.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 Ne Mother Joseph Pl, Suite 210, Vancouver, WA 98664 Phone: 360-254-6161 Fax: 360-449-1139 |